deneme bonusu Betturkey giriş casibom News & Updates – Ferozsons Laboratories Limited

News & Updates

Ferozsons Laboratories Limited collaborates with Rizq Foundation under its Omega Initiative to combat hunger

Lahore, 16th April 2021: Ferozsons Laboratories Limited, a leading pharmaceutical company, has signed a Memorandum of Understanding (MOU) with Rizq, an innovative social enterprise dedicated to ending hunger in Pakistan, to launch the Ferozsons Omega Initiative. The initiative aims to improve access of food at hospitals and underserved communities across Pakistan. In line with the UN sustainable development goals, the Ferozsons Omega Initiative also works to create awareness around the wastage of food.

Read More

Ferozsons Laboratories salutes Healthcare Heroes by lighting National Monuments Blue

Lahore, 5th May 2021: To honour the selfless efforts and sacrifices made by doctors, nurses, paramedics and frontline health workers during the ongoing pandemic, Ferozsons Laboratories Limited, a leading pharmaceutical company, launched a nation-wide initiative to turn three iconic monuments - Faisal Mosque, the Lahore Fort, and Frere Hall - into beacons of blue light on 4th and 5th May. The activity took place with the collaboration and generous support of the Capital Development Authority (CDA), the Walled City of Lahore Authority (WCLA), Karachi Metropolitan Corporation (KMC), as well as the Ministry of Interior. The initiative aimed to pay tribute to the healthcare community, the unsung heroes of the pandemic.

Read More

4th August 2020

Ferozsons Laboratories and HospitALL partner to develop telehealth platform

LAHORE -As part of its efforts to combat Covid-19, Ferozsons Laboratories Limited, Pakistan’s leading pharmaceutical company, has announced a partnership with HospitALL (a NETSOL Technologies incubated Startup) to develop a cutting-edge “Physician-Patient Virtual Counseling Platform”. Ferozsons, through its subsidiary BF Biosciences Limited, has produced remdesivir injections, under the brand name Remidia, under license and technology transfer from Gilead Sciences Inc., the company that received USFDA emergency use authorization for treatment of Covid-19 patients.

Read More

17th July 2019

Gilead Announces a Corporate Coalition with 12 Leading Companies to Eliminate Viral Hepatitis in Pakistan by 2030

Gilead Sciences, Inc. today announced that it has partnered with 12 leading companies in Pakistan as part of the Corporate Coalition for Viral Hepatitis Elimination in Pakistan (CCVHEP) program to support the Government of Pakistan’s effort to eliminate viral hepatitis in Pakistan by 2030.

Read More



21st February 2019

Ferozsons and Health Net Pakistan collaborate to tackle Diabetes

Ferozsons has collaborated with Health Net Pakistan to provide an innovative Diabetes management and training Continuous Medical Education (CME) programme for the primary care healthcare professionals.

Read More



1st October 2018

Project ECHO by Health Net Pakistan collaborates with Ferozsons

Ferozsons collaborated with HealthNet Pakistan that is responsible for running Project ECHO under the leadership of Dr. Asad Chaudhary. The collaboration raises awareness for hepatitis and is a part of a multi-tier approach to address the issue of rising hepatitis infections in Pakistan.

Read More



2nd September, 2018

Awareness on Drug Safety and Adverse Events reporting emphasized


Ferozsons Laboratories Limited has a rich legacy of standing by its values and ‘Putting Patients First’ is the forerunner amongst our values. A recent campaign on raising awareness for Drug Safety and Adverse Events reporting is line with our commitment for patient centricity in everything we do. For patients and physicians, it is very important to be aware of drug safety and adverse events reporting. To this end, Ferozsons launched a social media campaign via which we aim to help people understand the value of reporting any side effects they may have after using a certain medicine.
Read More



10th August, 2018

Ferozsons Launches the Hepatitis Free Pakistan Movement

As a leader in the Hepatology market Ferozsons Laboratories Limited launched a social media movement to spread awareness about viral Hepatitis
Read More





28 July 2018

Ferozsons and Jang Group Collaborate For a Noble Cause

This year Ferozsons Laboratories Limited in collaboration with the Jang Group organized a seminar to celebrate The World Hepatitis Day which is observed on July 28 to promote awareness of the disease that can sensitize the world leaders, doctors and researchers to strive to thwart it across the board from permeation. Leading Gastroenterologists and Hepatoglists including Prof. Anwaar A. Khan, Prof. Ghias un Nabi Tayyab, Prof. Irshad Hussain were present to name a few. CEO of Ferozsons, Osman Khalid Waheed also spoke on the importance linking the undiagnosed patients to cure.

Read More


27 June 2018

TED-Gilead Video Features Ferozsons

TED and Gilead partnership featured Ferozsons on the efforts made to address the high burden of Hepatitis in Pakistan. The micro-documentary produced by TED features the interview of CEO, Ferozsons Laboratories Limited, Osman Khalid Waheed. The aim of the video is to highlight Gilead and Ferozsons efforts in Pakistan.  This is the second time that Pakistan is in focus on a global scale by Gilead and the first in an external partnership with the exemplary TED. Ferozsons is proud of this selection and honored to be featured on the global scale.

                                            Read More

11 May 2018

Advancing Hepatology Education

In continuation to the commitment of expanding medical education in the critical area of Hepatology, Ferozsons supported a landmark series of certificate courses on liver diseases to over 250 physicians across Pakistan. This certificate course on liver diseases was conducted by Pakistan Society of the Study of Liver Diseases (PSSLD) in association with the International Coalition of Hepatology Education Providers (IC-HEP) and the Department of Medicine, Agha Khan University Hospital (AKUH)...

Read More

14 April 2018

Ferozsons launched DiaResQ

Ferozsons Laboratories Limited in partnership with PanTheryx Inc. an innovative US life science company launched DiaResQ sachets, a breakthrough nutritional innovation for diarrhoea relief in children and adults. The product was launched during various seminars held across Pakistan in the presence of leading pediatricians....

Read More

14 Mar 2018

Ferozsons collaborates with Ali Institute of Education for Hep C awareness in schools

Ferozsons Laboratories Limited and Ali Institute of Education collaborated to take the message of Hepatitis awareness and prevention to schoolchildren across a number of districts in Punjab. The aim of this campaign is to create awareness in children so they are able to take the message to their families and help in prevention from the viral disease that has a prevalence (Hepatitis B & C) of up to 10% in Pakistan, according to various estimates...

Read More

23 Feb 2018

Ultrasound Trainings kick off in DHQ Sheikhupura

Punjab Government’s Primary and Secondary Healthcare Department, General Electric Healthcare and Ferozsons Laboratories Limited have collaborated to deliver comprehensive training program for Maternal, Newborn & Child Health (MNCH) including a series of application training classes and knowledge transfer sessions led by international and local trainers, at Shahbaz Sharif Mother & Children Complex, Sheikhupura. The complex is part of the District Headquarters Hospital and will be the first such centre to deliver training programs focused on the use of ultrasound technology for primary healthcare workers...

Read More

03 Nov 2017

Ferozsons supports Movenpick’s “Kilo of Kindness” campaign

A Kilo of Kindness for a treat of ice cream’ is a global CSR campaign by Mövenpick Hotels & Resorts in which the Mövenpick properties collect learning supplies such as books and stationary for students of less privileged backgrounds. Mövenpick Hotel Karachi has also taken part in the campaign where school supplies were collected for a small charitable educational institute i.e. “The Street School” run by two enthusiastic teenagers in the city. Ferozsons Laboratories Limited lent support to this campaign as a corporate citizen that will help in equipping school supplies to the kids at the school. Our CSR vision is always...

Read More

30 Oct 2017

GE Healthcare signs MOU with Punjab government to train primary care workers

GE Healthcare signed an MOU with the Punjab Government to help train primary healthcare workers such as the Lady Health Workers and Community Midwives in ultrasound technology. Under this MOU, a training facility will be established by the Punjab Government and GE to provide hands on training according to globally designed manuals by international experts. The master trainers will be trained by international experts. The training centre will be established at Shehbaz Sharif Mother and Children Complex located within the District Head Quarter hospital, Sheikhupura. 60% of the country’s population resides in Punjab and there....

Read More

15 Oct 2017

EMERALD program launched by Ferozsons and Pakistan Society of Hepatology for Physicians

Ferozsons Laboratories Limited in partnership with and under the guidance of Pakistan Society of Hepatology (PSH) launched a Primary Care Physician Learning Initiative titled EMERALD. Expanding Primary Care Capacity to Treat Liver Diseases (EMERALD) program aims to equip physicians with the knowledge of correct diagnosis and treatment for managing Hepatitis C infections in Pakistan. Hepatitis C infections are a major cause of chronic liver disease and cirrhosis in the country and Pakistan has the second highest burden of Hepatitis C with over 10 million estimated patients suffering from this virus. The World Health Organiz....

Read More

02 Aug 2017

Ferozsons determined to combat Hepatitis till its elimination

The elimination of viral hepatitis has now been firmly put on the map. At the 69th World Health Assembly in Geneva, 194 governments adopted WHO’s Global Strategy on Viral Hepatitis, which includes a goal of eliminating hepatitis B and C in the next 13 years. The community responded by launching NOhep, the first ever global movement to eliminate viral hepatitis by 2030. On World Hepatitis Day 2017, Ferozsons Laboratories Limited, a leader in hepatology built on this momentum to accelerate progress towards achieving the goal of elimination by 2030. Ferozsons conducted a number of activities across Pakistan in major hospital....

Read More

30 Jul 2017

Ferozsons Laboratories Limited proud to be featured in Forbes

Forbes has released Asia’s best 200 companies under a billion (USD) list for 2017. Among many other top Asian companies, Ferozsons Laboratories Limited has been featured in this list for the second consecutive year. Ferozsons Laboratories, which made it to the list for the second time, grew 93 per cent last year, Forbes said. According to Forbes, the induction of a company in the list is based on company’s profitability and growth and if their annual revenue does not surpass $1 billion. The media outlet does not include companies that have worrisome accounting, management, and legal issues. This year almost 18,000 candi....

Read More

16 Mar 2017

Lahore Literary Festival 2017 – a breath of fresh air in the country

Forbes has released Asia’s best 200 companies under a billion (USD) list for 2017. Among many other top Asian companies, Ferozsons Laboratories Limited has been featured in this list for the second consecutive year. Ferozsons Laboratories, which made it to the list for the second time, grew 93 per cent last year, Forbes said. According to Forbes, the induction of a company in the list is based on company’s profitability and growth and if their annual revenue does not surpass $1 billion. The media outlet does not include companies that have worrisome accounting, management, and legal issues. This year almost 18,000 candi....

Read More

02 Mar 2017

Art breathes life in clinical settings

Ferozsons has been working closely with artists and the art community over the years to explore how it can play a positive role in clinical settings. Projects utilizing art for improved healthcare were carried out including the patient’s ward at Mayo Hospital in Lahore and patient’s waiting area at Jinnah Postgraduate Medical Center in Karachi. Both these projects make an effort to bring a pleasant change to the otherwise mundane environs of the hospitals. A new project with the help of Ziauddin University Hospital is now complete that has painted the kid’s play area in an exciting mélange of colours. Adeela Suleman, Head ....

Read More

02 Mar 2017

PepsiCo Pakistan collaborates with Ferozsons Laboratories for Hepatitis C awareness

Ferozsons Laboratories Limited is making efforts to spread the message of awareness and prevention against Hepatitis C to multiple stakeholders in the society. A part of this effort is to reach out to private sector companies to further the cause of the elimination of Hepatitis C. PepsiCo Pakistan, taking a leadership role in this area, collaborated with Ferozsons Laboratories Limited to spread the message of awareness and prevention at their head office to educate the employees. The kickoff session carried information about the disease, followed by screening of Hepatitis C, as well as a presentation form a renowned hepat....

Read More

28 Feb 2017

Community Projects Promise Elimination Of Hepatitis

Ferozsons Laboratories Limited is committed to the cause of hepatitis elimination with experience spanning a decade in providing world class treatments in Hepatology provided to thousands of patients across Pakistan. A new project that works with and in the communities is leading to new partnerships that promise appropriate screening, prevention and treatment of Hepatitis C patients. The community based projects, a pilot of which is being run at two locations in Central Punjab with some of the leading NGO's and community clinics engaged in liver care, is not only screening patients but is also looking at educating communit....

Read More

28 Dec 2016

Ferozsons partners with GE Healthcare

Ferozsons partners with GE Healthcare Ferozsons Laboratories Limited has entered into a non-exclusive international distribution agreement with GE Healthcare FZE. The agreement is effective as of the 1st of June 2016 until 31st of May 2017, and is subject to annual review. Under the agreement, Ferozsons will promote and sell the following selected GE Healthcare products in Pakistan: • Non-exclusive rights for promotion and sale for the Value Segment of Ultrasound products which includes; LOGIQ V series; LOGIQ C series; LOGIQ F series; Vscan series; Voluson P6; Voluson P8; Vivid T8; View Point; Echo Pac and Im....

Read More

05 Dec 2016

Ferozsons organizes Liver Summit 2016

Ferozsons organized the sixth annual Liver Summit 2016 with support from Gilead Sciences, Inc. in partnership with International Association for the Study of the Liver (IASL). Established in 1958, IASL is the oldest professional association of clinicians and scientists dedicated to translating liver research into clinical practice through national, regional, and international educational activities. Gilead and Ferozsons to organize the sixth annual session for Pakistani clinicians who benefit from the latest the latest scientific and evidence-based research studies shared by leading international experts. In the last six....

Read More

29 Sep 2016

Ferozsons committed to advancing heart health

Ferozsons Laboratories Limited has a history of introducing breakthrough products for heart health over the years, and is proud of its heritage of serving one of the most prevalent non-communicable diseases (NCDs) in Pakistan through a portfolio of holistic solutions that include pharmaceuticals and medical devices. Historically, the company has introduced new molecules and generics as a result of international collaboration and local expertise in the field of medicine. From management of blood pressure to high cholesterol, and treatment of angina and heart failure, Ferozsons’ portfolio for heart health caters to the medic....

Read More

28 Jul 2016

Ferozsons celebrates World Hepatitis Day

Ferozsons Laboratories Limited is celebrating the World Hepatitis Day by holding a number of activities. As a market leader in Hepatology, the company is working on initiatives with healthcare professionals, general public and the community organizations to spread the message of hepatitis prevention, awareness and access to treatment. In some key initiatives, a Hepatitis C awareness pamphlet that will be circulated to doctors and patients, has been designed. A supplement marking World Hepatitis Day with special messages from Pakistan Society of Gastroenterology, Pakistan Society of Hepatology and Pakistan Society for the S....

Read More

16 Jun 2016

Ferozsons amongst 27 companies as Pakistan secures Emerging Markets rating

Morgan Stanley Capital International (MSCI) announced to include Pakistan in the Emerging Markets category from Frontier Markets. The formal inclusion will be done in 2017. Emerging Markets inclusion means reducing the number of listed companies from 36 to 27 in indices. Ferozsons Laboratories is featured in the 27 and is clubbed with the small market cap companies. In the last few years, Ferozsons witnessed an incredible trajectory of growth and is now amongst the top ten pharmaceutical companies in Pakistan. The status awarded to Pakistan by MSCI is a testament to the good performance of the stock exchanges in the recent....

Read More

30 May 2016

Gilead and Ferozsons’ Hepatitis C Access Program appreciated

A recent report published by leading business daily, the Business Recorder, appreciates the partnership between Ferozsons Laboratories Limited and Gilead Sciences Inc. to implement the Access Program for Hepatitis C Virus (HCV), offering the breakthrough treatment, Sovaldi in Pakistan at a fraction of its international cost. Under the second phase of this access program, Ferozsons will now be manufacturing the first locally produced authorized generic of the drug Sovaldi at a highly reduced cost to reach an even larger number of patients in Pakistan. The report suggests that access programs that bring innovative and breakt....

Read More

29 May 2016

Saving hearts with latest technology of Rotablation

Ferozsons Laboratories Limited, the authorized distributor for Boston Scientific Corp., a global leader in medical devices manufacturing, organized a workshop at the Hayatabad Medical Complex (HMC) in Peshawar. The Rotablator workshop was successfully conducted and is named after the technology that is making it possible to remove calcium from blocked arteries and to put stents in patients suffering from coronary artery disease. An expert Interventional Cardiologist trained in the UK led the local team of Cardiologists and carried out this specialized procedure. The session targeted at engaging with Interventional Cardiolo....

Read More

16 May 2016

Ferozsons to manufacture first authorized generic

Ferozsons Laboratories Limited has recently obtained the manufacturing license along with requisite production process technology from Gilead Sciences, Inc. to manufacture an authorized generic of the breakthrough Hepatitis C Virus (HCV) treatment in Pakistan. The generic treatment is priced at a fraction of the originator access price in Pakistan. With this approval, Ferozsons is furthering its mission to expand the cure to new patients suffering from this deadly disease. Availability of this authorized generic version of the HCV treatment at such a reduced price will further expand quality treatment access to HCV cure ....

Read More

09 May 2016

Ferozsons celebrates World Hypertension Day 2016

Ferozsons recently celebrated the World Hypertension Day in partnership with our customers and by arranging several patient awareness and general information programs across Pakistan. Top cardiologists and hypertension specialists spoke on the importance of this day and the grave challenges the disease poses to a large population in Pakistan. High blood pressure as it is commonly called, is known to be a ‘silent killer’ and is a leading cause of morbidity around the world. Pakistan Hypertension League states that Hypertension is the number 1 chronic health problem in Pakistan with approximately 50% of all adults at risk of....

Read More

11 Apr 2016

Using art to impact public health spaces

Ferozsons supported to initiate the first project in Karachi at the Jinnah Post-Graduate Medical Centre (JPMC). The project titled, Innovations in Public Space is done in collaboration with the Patient’s Aid Foundation, working at the JPMC for the benefit of poor patients. Baithak is the name given to the revamped space which was an informal waiting area for patients. Artist Naima Chaudhry designed the space that provides shade from the sun, comfortable seating and access to water and other basic necessities. This is just one of the many initiatives that planned by the LBF under Innovations in Public Space. ....

Read More

31 Mar 2016

Ferozsons is fastest growing amongst all pharma cos

Ferozsons has become the fastest growing pharmaceutical company in Pakistan amongst the top ten companies, revealed the first quarter 2016 report issued by healthcare information monitor, IMS Health. In the last two years, Ferozsons has witnessed unprecedented growth mainly due to the Hepatitis C Virus (HCV) franchise. Ferozsons is now ranked no. 6 amongst the top ten corporates and has secured third place amongst national companies. This is a great achievement and what better year to do this as the company is set to complete 60 years of operations in Pakistan. Ferozsons is planning to continue on this growth trajectory ....

Read More